- Report
- February 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- August 2023
- 150 Pages
Global
From €4109EUR$4,250USD£3,529GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- April 2020
- 156 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- May 2022
- 140 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- October 2021
- 101 Pages
Global
From €3867EUR$4,000USD£3,322GBP
- Report
- October 2021
- 311 Pages
Global
From €3867EUR$4,000USD£3,322GBP
- Report
- February 2023
- 316 Pages
Global
From €5540EUR$5,730USD£4,758GBP
The Impella market is a segment of the cardiovascular device industry that focuses on the development and production of mechanical circulatory support systems. These systems are designed to provide temporary support for the heart, allowing it to rest and recover from a variety of conditions. Impella devices are typically used in the treatment of acute heart failure, cardiogenic shock, and other conditions that require short-term circulatory support.
The Impella market is highly competitive, with a number of companies offering a range of products. These include Abiomed, Medtronic, St. Jude Medical, and Terumo Corporation. Other companies in the market include Berlin Heart, CardiacAssist, and SynCardia Systems. Show Less Read more
